The mek1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma

  • Mikhail S. Chesnokov
  • , Imran Khan
  • , Yeonjung Park
  • , Jessica Ezell
  • , Geeta Mehta
  • , Abdelrahman Yousif
  • , Linda J. Hong
  • , Ronald J. Buckanovich
  • , Akimasa Takahashi
  • , Ilana Chefetz

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1369
Pages (from-to)1-20
Number of pages20
JournalCancers
Volume13
Issue number6
DOIs
StatePublished - Mar 2 2021

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Cancer stem-like cells
  • High-grade serous ovarian carcinoma
  • MEK1/2
  • Proliferation
  • Trametinib

Cite this